ArticleBritish journal of pharmacology2006

Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase.

Gerald Wölkart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.